HFA Icon

Leaked TPP Trade Agreement Shows Seniors Disadvantaged

HFA Padded
Mark Melin
Published on
Updated on
Sign up for our E-mail List and Get FREE Access to Exclusive Investment E-books and More!

The Trans Pacific Partnership agreement, labeled a free-trade agreement by some, would actually work to provide large pharmaceutical firms unprecedented advantage against cheaper generic drugs, reducing competition, a POLITICO report concluded. The resulting agreement is by design targeting to enrich the largest pharmaceutical companies, but the unintended consequences could damage the burgeoning U.S. generic pharmaceutical industry. But the TPP's worst impact could be felt by seniors, who may be practically restricted from accessing life saving treatments.

Trans-Pacific Partnership TPP
Trans-Pacific Partnership (TPP)

One leaked chapter of the agreement has POLITICO’s head spinning

Working off a leaked copy of...

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article
Already a member? Log in here
HFA Padded

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.